Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million peopleSpecial Populations Published on 2020-10-312022-10-31 Journal: Heart (British Cardiac Society) [Category] COVID-19, MERS, SARS, [키워드] 95% CI ACE ACE inhibitor adjusted Admission African angiotensin receptor blocker ARB association black cardiac risk factors and prevention cohort study collected data confounders COVID-19 COVID-19 disease Cox proportional hazard diabetes diagnosed disease drug Effect England enzyme Epidemiology ethnic group finding geographical region group higher risk hypertension ICU ICU care increased risk inhibitor intensive care medication participant Patient primary care Primary outcome prospective cohort study raise receiving receptor reduced risk resulting risk risk of COVID-19 RT-PCR severe COVID-19 disease severity significant interaction significantly significantly increased sociodemographic factors susceptibility variables with COVID-19 [DOI] 10.1136/heartjnl-2020-317393 PMC 바로가기 [Article Type] Special Populations
Observational data during the COVID-19 pandemic: opportunity with uncertaintyEditorial Published on 2020-10-012023-07-06 Journal: Heart (British Cardiac Society) [Category] SARS, [키워드] cardiac risk factors and prevention epidemiology. [DOI] 10.1136/heartjnl-2020-317486 PMC 바로가기 [Article Type] Editorial
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysisMeta-Analysis Published on 2020-10-012023-07-06 Journal: Heart (British Cardiac Society) [Category] SARS, [키워드] cardiac risk factors and prevention hypertension Meta-analysis. [DOI] 10.1136/heartjnl-2020-317336 PMC 바로가기 [Article Type] Meta-Analysis
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19Article Published on 2020-10-012023-07-11 Journal: Heart (British Cardiac Society) [Category] SARS, [키워드] cardiac risk factors and prevention Coronary artery disease global health myocardial disease systemic inflammatory diseases. [DOI] 10.1136/heartjnl-2020-317322 PMC 바로가기
Cardiovascular manifestations and treatment considerations in COVID-19Article Published on 2020-08-302023-06-14 Journal: Heart (British Cardiac Society) [Category] MERS, SARS, [키워드] cardiac risk factors and prevention myocarditis systemic inflammatory diseases [DOI] 10.1136/heartjnl-2020-317056 PMC 바로가기